Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 14/20 | 0.66 |
| ▸ | CNR2 | P34972 | 7/20 | 0.58 |
| ▸ | PPARA | Q07869 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4890177 | 0.92 | CNR1 (0.78) | CNR1 | |
| SCHEMBL14087102 | 0.88 | CNR1 (0.61) | CNR1CNR2PPARA | |
| SCHEMBL4632902 | 0.88 | CNR1 (0.85) | CNR1CNR2 | |
| SCHEMBL4882114 | 0.84 | CNR1 (0.68) | CNR1CNR2PPARA | |
| SCHEMBL4888372 | 0.83 | CNR1 (0.59) | CNR1CNR2PPARA | |
| SCHEMBL4878527 | 0.83 | CNR1 (0.57) | CNR1CNR2PPARA | |
| SCHEMBL4887625 | 0.82 | CNR1 (0.58) | CNR1CNR2PPARA | |
| SCHEMBL4884798 | 0.80 | CNR1 (0.61) | CNR1CNR2PPARA | |
| SCHEMBL4878550 | 0.79 | CNR1 (0.54) | CNR1CNR2PPARA | |
| SCHEMBL4888376 | 0.78 | CNR1 (0.55) | CNR1CNR2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200527-A1 | Cannabinoid Receptor Modulators | CAREX SA (FR) | 2008-08-21 | — | — | US | disclosed |
| US-20080200527-A1 | Cannabinoid Receptor Modulators | CAREX SA (FR) | 2008-08-21 | — | — | US | disclosed |
| US-20080200527-A1 | Cannabinoid Receptor Modulators | CAREX SA (FR) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200527-A1 | Cannabinoid Receptor Modulators | CNR1, CNR2, HCRTR2 | CNR1 1/4885CNR2 2/4885PPARA 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.